[go: up one dir, main page]

UY30785A1 - SUBSTANTIELY PURE FLUORESCEINE - Google Patents

SUBSTANTIELY PURE FLUORESCEINE

Info

Publication number
UY30785A1
UY30785A1 UY30785A UY30785A UY30785A1 UY 30785 A1 UY30785 A1 UY 30785A1 UY 30785 A UY30785 A UY 30785A UY 30785 A UY30785 A UY 30785A UY 30785 A1 UY30785 A1 UY 30785A1
Authority
UY
Uruguay
Prior art keywords
substantiely
fluoresceine
pure
substantially pure
pure fluorescein
Prior art date
Application number
UY30785A
Other languages
Spanish (es)
Inventor
Britt S Scott
Gregg Robert Harris
Gregory Bydlinski
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Priority to UY30785A priority Critical patent/UY30785A1/en
Publication of UY30785A1 publication Critical patent/UY30785A1/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

El presente invento se refiere a un proceso mejorado para producir fluoresceína sustancialmente pura así como a composiciones de fluoresceína sustancialmente pura preparadas mediante dicho proceso. El invento se refiere especialmente al suministro de composiciones farmacéuticas par su uso en angiografías. La fluoresceína sustancialmente pura producida por el proceso del presente invento es de color bajo, tiene contenido de cloruro de sodio y esta sustancialmente libre de piridina.The present invention relates to an improved process for producing substantially pure fluorescein as well as substantially pure fluorescein compositions prepared by said process. The invention especially relates to the supply of pharmaceutical compositions for use in angiography. The substantially pure fluorescein produced by the process of the present invention is low in color, has sodium chloride content and is substantially free of pyridine.

UY30785A 2007-12-12 2007-12-12 SUBSTANTIELY PURE FLUORESCEINE UY30785A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY30785A UY30785A1 (en) 2007-12-12 2007-12-12 SUBSTANTIELY PURE FLUORESCEINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY30785A UY30785A1 (en) 2007-12-12 2007-12-12 SUBSTANTIELY PURE FLUORESCEINE

Publications (1)

Publication Number Publication Date
UY30785A1 true UY30785A1 (en) 2008-05-31

Family

ID=39472754

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30785A UY30785A1 (en) 2007-12-12 2007-12-12 SUBSTANTIELY PURE FLUORESCEINE

Country Status (1)

Country Link
UY (1) UY30785A1 (en)

Similar Documents

Publication Publication Date Title
MX2009005679A (en) Substantially pure fluorescein.
UY32648A (en) NEW DERIVATIVES OF PYRIMIDINE AND ITS USE IN THE TREATMENT OF DISEASES
GT200600084A (en) IVABRADINE CHLORIDE HYDROCHLET BETA FORM, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
MX2019003738A (en) ANTIVIRAL COMPOUNDS.
BR112012004157B8 (en) biomaterials, process of mixing acp with hbc and their use
ECSP12011964A (en) ANTIBODIES OF UNION TO THE EXTRACELLULAR DOMAIN 4 OF CSF-1R
MX2020008468A (en) IMPROVEMENT OF AUTOPHAGY OR INCREASE IN LONGEVITY BY ADMINISTRATION OF UROLITINS OR PRECURSORS THEREOF.
BR112012028291A2 (en) pharmaceutical compositions and methods for their production
CO6450612A2 (en) SUBSTITUTED 1-CYANOETHYLETHYCLIC CARBOXAMIDE 750 COMPOUNDS
CO6630147A2 (en) Sweet Taste Modifier
CU20110239A7 (en) PHARMACEUTICAL COMPOSITION FOR EMERGENCY ANTI-CONCEPT
BR112012013847A2 (en) new indolinone cyclopropane derivatives
CR8246A (en) GAMMA-D CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY31870A (en) METABOTROPIC RECEIVER OF POTENTIAL GLUTAMATE 286
BRPI0924653B8 (en) iron-oligosaccharide compound, composition and use of this compound
UY32517A (en) DERIVATIVES OF NICOTINAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
BR112012013487A2 (en) AMANTADINE COMPOSITIONS AND METHODS OF USE
BR112014018032A2 (en) method to produce a composition
CO6351723A2 (en) DERIVATIVES OF PIRAZOLO- [5,1-B] -OXAZOL AS AN ANTIGONIST OF CRF1
UY32010A (en) NEW INDOLINONES, COMPOSITIONS CONTAINING AND APPLICATIONS
BRPI1008855B8 (en) indole derivatives, their use as anticancer agents, their process for preparation and pharmaceutical composition comprising them
ECSP109961A (en) DERIVATIVES OF INDOL-2-ONA DISSTITUTED IN 3, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
UY32744A (en) DERIVATIVES OF 2-CARBOXAMIDA-7-PIPERAZINIL-BENZOFURANO 774
UY31138A1 (en) DERIVATIVES OF SUBSTITUTED INDOLINONES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
MX2011012688A (en) COMPOSITION OF NON-BINDING SALT, PROCESS OF PREPARATION AND USE OF THE SAME.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200115